Abstract

Biotechnology Law ReportVol. 26, No. 2 Regulatory Affairs—PharmaceuticalFDA Expands Medical Product Safety Program; Industry Criticizes Draft Guidance for Regulating Multivariate Index Assays; Congress Makes Another Attempt to Pass a Genetic Nondiscrimination Bill; USDA Approves Bacteriophage Product; Farewell to Paper?; FDA Approves Drug for Fat Dogs; FDA Approves Suture Made by Genetically Engineered Bacteria; Pharmacogenomics Products May Have Better Chance Than New Drug at FDAPublished Online:30 Apr 2007https://doi.org/10.1089/blr.2007.9969AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byUse of Bacteriophages to Control Escherichia coli O157:H7 in Domestic Ruminants, Meat Products, and Fruits and Vegetables Lili Wang, Kunli Qu, Xiaoyu Li, Zhenhui Cao, Xitao Wang, Zhen Li, Yaxiong Song, and Yongping Xu1 September 2017 | Foodborne Pathogens and Disease, Vol. 14, No. 9Phage-based biocontrol strategies to reduce foodborne pathogens in foods22 October 2014 | Bacteriophage, Vol. 1, No. 3 Volume 26Issue 2Apr 2007 InformationMary Ann Liebert, Inc.To cite this article:FDA Expands Medical Product Safety Program; Industry Criticizes Draft Guidance for Regulating Multivariate Index Assays; Congress Makes Another Attempt to Pass a Genetic Nondiscrimination Bill; USDA Approves Bacteriophage Product; Farewell to Paper?; FDA Approves Drug for Fat Dogs; FDA Approves Suture Made by Genetically Engineered Bacteria; Pharmacogenomics Products May Have Better Chance Than New Drug at FDA.Biotechnology Law Report.Apr 2007.121-123.http://doi.org/10.1089/blr.2007.9969Published in Volume: 26 Issue 2: April 30, 2007PDF download

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.